Abnormal myocardial uptake and clearance of123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction

Journal of Nuclear Cardiology

Volumn 3, Issue 6 PART I, 1996, Pages 508-515

  Miyanaga, Hajime ^a   Yoneyama, Satoshi ^a   Kamitani, Tadaaki ^a   Kawasaki, Shingo ^a   Takahashi, Toru ^a   Kunishige, Hiroshi ^a  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

Author keywords

123l labeled metaiodobenzylguanidine myocardial scintigraphy; Autonomie disturbance; Chronic renal failure; Power spectral analysis

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CREATININE; IODINE 123;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG CLEARANCE; DRUG UPTAKE; FEMALE; HEART SCINTISCANNING; HUMAN; MALE; MEDIASTINUM; NORMAL HUMAN; POWER SPECTRUM; PRIORITY JOURNAL; RR INTERVAL;

3-IODOBENZYLGUANIDINE; AUTONOMIC NERVOUS SYSTEM DISEASES; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; SIGNAL PROCESSING, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030453542     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1071-3581(96)90060-4     Document Type: Article

References (22)

1. 131I] iodobenzylguanidine. J Nucl Med 1980;21:349-53.
2. Klin RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, et al. Myocardial imaging in man with 1-123 metaiodobenzylguanidine. J Nucl Med 1981;22:129-132.
3. 201Tl myocardial SPECT. Jpn J Nucl Med 1990;27:709-718.
4. 201Tl-C1-SPECT. Jap J Nucl Med 1990;27:821-31.
5. 201TlCl myocardial imaging. Jpn J Nucl Med 1989;26:419-423.
6. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192-1199.
7. Mantysaari M, Kukka J, Mustonen J, Tavanainenet K, Vanninen E, Lansimies E, et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [1 2 3 I] Metaiodobenzylguanidine. Diabetes 1992;41:1069-1075.
8. Nakajo M, Shimabukuro K, Miyaji N, Shimada J, Shirono K, Sakata H, et al. Rapid clearance of iodine-131-MIBG from the heart and liver of patients with adrenergic dysfunction and pheochromocytoma. J Nucl Med 1985;26:357-365.
9. Ohtomo N, Terachi S, Tanaka Y. Nonlinear time series analysis, 1: a new method of analysis and theoretical background. Bull Fac Eng Hokkaido Univ 1991;158:43-55.
10. Tanaka Y, Ohtomo N, Terauchi S. Nonlinear time series analysis 6: on the MEM spectrum for cyclic function. Bull Fac Eng Hokkaido Univ 1993;163:47-52.
11. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482-92.
12. Hirahara Y, Nakamura C, Yamazaki T, Matsuda S, Fujita E, Mashima H, et al. Evaluation of autonomie functions in regular hemodialysis patients: Pathogenesis and management of orthostatic hypotension. J Hemodialysis 1991;24:1098-1104.
13. Kersh ES, Kronfield SJ, Unger A, Popper RW, Cantor S, Cohn K. Autonomie insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 1974;290:650-3.
14. Hennessy WJ, Siemsen AW. Autonomie neuropathy in chronic renal failure. Clin Res 1968:16:385.
15. Kimura M, Iseda K. Autonomie nerve dysfunction in chronic renal failure. Nihon Rinsyo Meneki Gakkai Kaishi 1992;50:830-5.
16. Ewing DJ, Winney R. Autonomie function in patients with chronic renal failure on intermittent hemodialysis. Nephron 1975;15:424-9.
17. Lazarus JM, Hampers CL, Lowrie EG, Merrill JP. Baroreceptor activity in normotensive and hypertensive uremic patients. Circulation 1973:47:1015-21.
18. Agarwal A, Anand IS, Sakhuja U, Chugh KS. Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int 1991;40:489-95.
19. Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, et al. Assessment of autonomie function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-H153.
20. Pagani M, Lambardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli E, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-193.
21. Binkley PF, Nunziata E, Haas GJ, et al. Parasympathetic withdrawal is an integral component of autonomie regulation imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991;18:464-72.
22. Ueda N. Detection of diabetic autonomie neuropathy: utilization of power spectral analysis of heart rate variability. J Jpn Diabetes Soc 1992:35:17-23.